Pure Global

Improving Implementation of Evidence-based Approaches and Surveillance to Prevent Bacterial Transmission and Infection - Trial NCT04600973

Access comprehensive clinical trial information for NCT04600973 through Pure Global AI's free database. This phase not specified trial is sponsored by Trustees of Dartmouth College and is currently Not yet recruiting. The study focuses on Infection. Target enrollment is 6000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT04600973
Not yet recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT04600973
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Improving Implementation of Evidence-based Approaches and Surveillance to Prevent Bacterial Transmission and Infection
The BASIC Trial: Improving Implementation of Evidence-based Approaches and Surveillance to Prevent Bacterial Transmission and Infection

Study Focus

Infection

Technical assistance or team-based coaching

Interventional

behavioral

Sponsor & Location

Trustees of Dartmouth College

Iowa City,Hanover, United States of America

Timeline & Enrollment

N/A

Jul 01, 2021

Jun 30, 2026

6000 participants

Primary Outcome

ESKAPE Transmission Events

Summary

Surgical site infections (SSIs) are associated with increased patient morbidity, mortality,
 and healthcare costs. ESKAPE (Enterococcus, S. aureus, Klebsiella, Acinetobacter,
 Pseudomonas, and Enterobacter spp.) pathogens are particularly pathogenic because they have
 increased capacity to acquire resistance and virulence traits. The investigators have proven
 that a multifaceted program involving improved basic perioperative preventive measures can
 generate substantial reductions in S. aureus transmission and significant reductions in SSIs
 (88% reduction as compared to usual care). In this study, the investigators aim to examine
 the relative effectiveness of each component of this program in controlling ESKAPE
 transmission and reducing SSIs and to identify an optimal implementation strategy for
 national dissemination. Randomization occurs at the site level, and sites adopt preventative
 programs. This work will improve perioperative patient safety for the 51 million patients who
 undergo surgery each year.

ICD-10 Classifications

Bacterial infection, unspecified
Bacterial, viral and other infectious agents
Infection following immunization
Other infectious diseases
Viral infection, unspecified

Data Source

ClinicalTrials.gov

NCT04600973

Non-Device Trial